Common deficiencies in abbreviated new drug applications: part 1: Drug substance

被引:0
|
作者
Srinivasan, Aloka [1 ]
Iser, Robert [1 ]
机构
[1] Office of Generic Drugs, Office of Pharmaceutical Science, US Food and Drug Administration S Center for Drug Evaluation and Research, United States
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:50 / 59
相关论文
共 50 条
  • [1] Common bioanalytical deficiencies with bioequivalence submissions in Abbreviated New Drug Applications
    Williamson, Leah N.
    Conner, Dale P.
    Stier, Ethan M.
    Davit, Barbara M.
    BIOANALYSIS, 2014, 6 (04) : 441 - 445
  • [2] Common Deficiencies with Bioequivalence Submissions in Abbreviated New Drug Applications Assessed by FDA
    Liu, Qing
    Davit, Barbara M.
    Cherstniakova, Svetlana A.
    Dandamudi, Suman
    Walters, Johnetta F.
    Lee, Christina H.
    Raines, Kimberly W.
    Ren, Ke
    Williamson, Leeh N.
    Conner, Dale P.
    AAPS JOURNAL, 2012, 14 (01): : 19 - 22
  • [3] Common Deficiencies with Bioequivalence Submissions in Abbreviated New Drug Applications Assessed by FDA
    Qing Liu
    Barbara M. Davit
    Svetlana A. Cherstniakova
    Suman Dandamudi
    Johnetta F. Walters
    Christina H. Lee
    Kimberly W. Raines
    Ke Ren
    Leeh N. Williamson
    Dale P. Conner
    The AAPS Journal, 2012, 14 : 19 - 22
  • [4] Common Filing Deficiencies in Abbreviated New Drug Applications Containing Clinical Endpoint Studies
    Lewis J. Fermaglich
    Ru Chen
    Carol Y. Kim
    Eunjung Esther Chuh
    Teena Thomas
    Daiva Shetty
    Julia Lee
    Johnny Young
    Ying Fan
    Therapeutic Innovation & Regulatory Science, 2019, 53 : 81 - 85
  • [5] Common Filing Deficiencies in Abbreviated New Drug Applications Containing Clinical Endpoint Studies
    Fermaglich, Lewis J.
    Chen, Ru
    Kim, Carol Y.
    Chuh, Eunjung Esther
    Thomas, Teena
    Shetty, Daiva
    Lee, Julia
    Young, Johnny
    Fan, Ying
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2019, 53 (01) : 81 - 85
  • [6] Common Deficiencies of in vitro Binding Bioequivalence (BE) Studies Submitted in Abbreviated New Drug Applications (ANDAs)
    Liu, Dongmei
    Vivian, Diana
    Ren, Ping
    Yang, Yongsheng
    Zhang, Hongling
    Jiang, Xiaojian
    Stier, Ethan
    AAPS JOURNAL, 2018, 20 (02):
  • [7] Common Deficiencies of in vitro Binding Bioequivalence (BE) Studies Submitted in Abbreviated New Drug Applications (ANDAs)
    Dongmei Lu
    Diana Vivian
    Ping Ren
    Yongsheng Yang
    Hongling Zhang
    Xiaojian Jiang
    Ethan Stier
    The AAPS Journal, 20
  • [8] Assessment of Manufacturing Related Deficiencies for Modified Release Tablet in Abbreviated New Drug Applications
    Chen, Jim
    Wang, Zhouxi
    Shah, Rakhi
    Scherlitz, Anna
    Feng, Xin
    Chen, Jocelyn
    Wu, Larisa
    AAPS PHARMSCITECH, 2022, 23 (07)
  • [9] Assessment of Manufacturing Related Deficiencies for Modified Release Tablet in Abbreviated New Drug Applications
    Jim Chen
    Zhouxi Wang
    Rakhi Shah
    Anna Scherlitz
    Xin Feng
    Jocelyn Chen
    Larisa Wu
    AAPS PharmSciTech, 23
  • [10] Common chemistry, manufacturing, and control deficiencies in abbreviated new drug applications assessed by the US Food and drug administration: Hurdle to access cost-effective medicines
    Kulkarni, Samruddhi B.
    Gaikwad, Vinod L.
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2023, 123